Analyst Ratings for Eli Lilly (LLY)
LLY Rating Summary
LLY Price Target Summary
- Highest: $1,500.00 (Citi)
- Lowest: $700.00 (HSBC)
- Average: $1,210.12
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1,210.12 (+22.2%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
Avg. $ Target:
$1,210.12 (+22.2%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | RBC Capital | Trung Huynh | New Coverage | Outperform (N/A) |
1,250.00 (N/A) |
1058.56 (990.33) |
-6.45% | Details |
| 2/19/2026 | Barclays | Carter Could | New Coverage | Overweight (N/A) |
1,350.00 (N/A) |
1020.56 (990.33) |
-2.96% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
